Working… Menu
Trial record 5 of 12 for:    ravidasvir

A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03602300
Recruitment Status : Completed
First Posted : July 26, 2018
Last Update Posted : October 19, 2018
Information provided by (Responsible Party):
Drugs for Neglected Diseases

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 17, 2018
Actual Study Completion Date : August 17, 2018